FDA GFI, Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C of the FD&C Act, 03/20 Anna Sandberg2021-09-29T11:57:42+00:00September 29th, 2021|
FDA GFI, Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification, 06/21 Anna Sandberg2021-09-29T11:45:06+00:00September 29th, 2021|
PIC/S, Good practices for data management and integrity in regulated GMP/GDP enviroments, 07/21 Anna Sandberg2023-07-25T09:28:51+00:00September 29th, 2021|
MHRA, A Guide to Defective Medicinal Products, 08/21 Anna Sandberg2021-09-28T14:19:30+00:00September 28th, 2021|
EMA, Guidance, GMP/GDP and PMF distant assessments, 10/20 Felicia Kehr2021-09-17T13:47:23+00:00January 28th, 2021|
EU Aide Memoire GDP Inspection of Wholesalers Safety Features, 10/19 2022-10-04T14:52:20+00:00January 29th, 2020|